Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular DystrophyValeria Ricotti, Jonathon M. Tinsley, Helen Roper et al.|PLoS ONE|2016Cited by 53